1. Home
  2. CD vs NNNN Comparison

CD vs NNNN Comparison

Compare CD & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chaince Digital Holdings Inc. Ordinary Shares

CD

Chaince Digital Holdings Inc. Ordinary Shares

BUY

Current Price

$4.40

Market Cap

323.4M

Sector

Technology

ML Signal

BUY

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$5.75

Market Cap

340.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CD
NNNN
Founded
2011
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
323.4M
340.2M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
CD
NNNN
Price
$4.40
$5.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
194.8K
250.9K
Earning Date
08-31-2023
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,867,068.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
277.93
N/A
52 Week Low
$2.10
$5.13
52 Week High
$14.10
$51.33

Technical Indicators

Market Signals
Indicator
CD
NNNN
Relative Strength Index (RSI) N/A 28.72
Support Level N/A N/A
Resistance Level N/A $12.10
Average True Range (ATR) 0.00 0.44
MACD 0.00 0.07
Stochastic Oscillator 0.00 23.89

Price Performance

Historical Comparison
CD
NNNN

About CD Chaince Digital Holdings Inc. Ordinary Shares

Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: